A study in JAMA Network Open reveals a rise in drug-induced liver injuries associated with herbal supplements like green tea ...

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.

Many patients seek Chinese herbal medicines (CHM) from traditional Chinese medicine (TCM) clinics. This study aimed to estimate the risk of major adverse cardiovascular events (MACEs) in adults ...

Cai said that Asian Americans are such a heterogeneous population that the results from the study of the Chinese immigrants ...

For centuries, eastern and western medicines have operated in separate spheres. Now, a new approach to healthcare is taking ...

Lycium barbarum is a traditional and valuable medicinal herb in China. It has the effects of "strengthening muscles and bones ...